Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CELU
CELULARITY INC.
NASDAQ
$1.58
▼ DOWN 24.76% (-0.52)

KEY STATISTICS

Market Cap$45.73 M
52w High$3.15
52w Low$0.56
Dividend Yield—
Frequency—
P/E-0.44
Volume14.93M
Shares Out.28.95M

COMPANY

LEADERSHIP

Robert Joseph Hariri
CHIEF EXECUTIVE
Robert Joseph Hariri

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 8, 2019
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
115

PRICE TARGET

Target High$3.00
Target Low$3.00
Target Median$3.00
Target Consensus$3.00

UPCOMING EARNINGS

DateNov 13, 2026
DayFriday
Rev. Est.—
NOV
13
FRI

SPLIT RECORD

DATETYPERATIO
2024-02-29Reverse1:10

PRICE

$1.58 ▼ DOWN 24.76% (−$0.52)
OVERLAYS
$1.60$1.80$2.00$2.209:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.58

About Celularity Inc.

https://www.celularity.com ↗

Celularity Inc. is a biotech company developing off-the-shelf placental-derived cell therapies for cancer, immune, and infectious diseases, with programs in clinical and preclinical stages, and operates in biobanking and wound care markets.

INDUSTRY

Biotechnology

A PRODUCT CELULARITY INC. IS KNOWN FOR

Biovance®
Biovance®

Celularity's flagship regenerative medicine product is a human amniotic membrane allograft used in wound care and surgery, supporting tissue regeneration and recently benefiting from ongoing Medicare coverage.

COMPETITORS

COMPETITOR
IART COMPARE
MDWD COMPARE
MDXG COMPARE
ORGO COMPARE
SMTI COMPARE

Revenue by Products

IconPRODUCTQ1-2025Q2-2025Q3-2025Q4-2025
License Royalty and Other$1M $2.47M ▲$2.94M ▲$6.94M ▲
Service$1.41M $1.27M ▼$1.45M ▲$1.3M ▼
Product$9.02M $2.55M ▼$1.67M ▼$0 ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
VTS.AX
0.00% · 455.0K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
62.93%
HOLDERS
54
TOP 12 OF 54 · RANKED BY POSITION SIZE
Starr International Co Inc
15.3M sh · $3.36M
C V Starr & Co Inc
764.1K sh · $1.58M
Louis-Dreyfus Family Office LLC
720.0K sh · $1.66M
Vanguard Group Inc
676.6K sh · $751.08K
Geode Capital Management, LLC
191.1K sh · $254.17K
Blackrock, Inc.
127.5K sh · $169.57K
Yorkville Advisors Global, LP
100.0K sh · $207K
Citadel Advisors LLC
99.1K sh · $59.22K
Blackrock Inc.
90.7K sh · $284.04K
State Street Corp
57.8K sh · $119.71K
Hrt Financial LP
56.6K sh · $33K
Valmark Advisers, Inc.
50.0K sh · $66.48K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
10 PERCENT OWNER
Philip & Daniele Barach Family Trust
Sale · 1.2M shares
2026-06-19
★
10 PERCENT OWNER
Barach Philip Alan
Sale · 1.2M shares
2026-06-19
★
10 PERCENT OWNER
Barach Daniele Wolf
Sale · 839.2K shares
2026-06-19
★
10 PERCENT OWNER
Barach Philip Alan
Sale · 839.2K shares
2026-06-19

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
WBB Securities BUY

SECTORS PEERS

PEERPRICE
PYPD$5.07COMPARE
ANVS$1.72COMPARE
TPST$1.06COMPARE
RVPH$0.52COMPARE
BTAI$0.18COMPARE
BCAB$1.74COMPARE